A Study to Evaluate Corrected QT Interval and Drug-Drug Interaction of Trastuzumab on Carboplatin in the Presence of Docetaxel in Patients With HER2-Positive Metastatic or Locally Advanced Inoperable Cancer
Clinical trial NCT00927589 · COMPLETED
Trial details
- NCT number
- NCT00927589
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2013-02-01
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.